Return to program book search
Photodynamic Therapy in Difficult and High-Risk Patient Populations
Saturday, March 22
3:30 PM - 5:30 PM
Edward V. Maytin, MD, PhD, FAAD
- Fernanda H. Sakamoto, MD
- Emil A. Tanghetti, MD, FAAD
Following this course, the attendee should be able to:
- Identify patient populations with few other treatment options who might benefit from photodynamic therapy (PDT).
- Recognize the benefits and minimize the side effects of PDT in organ transplant patients and in patients with frequent, recurrent non-melanoma skin cancer.
- Acquire the latest information on new field treatment approaches using PDT combined with other modalities for prevention and treatment of skin cancer, and in certain hard-to-treat inflammatory skin diseases.
Photodynamic therapy (PDT) is now widely recognized in dermatology as an effective nonsurgical treatment modality for actinic keratoses (AK). However, new opportunities are developing within patient populations with few other treatment options. Data will be presented on the use of PDT in difficult or high-risk patients. Prospects for use of regular (cyclic) PDT to treat and prevent skin cancers in organ transplant patients, and in patients with the basal cell nevus syndrome, will be analyzed using literature review and clinical trial data. Use of PDT for recalcitrant inflammatory and granulomatous conditions (acne, hidradenitis, granuloma annulare) will also be covered.
|Saturday, March 22|
|3:30 PM||Basic principles for application of PDT in high risk skin cancer populations / Dr. Maytin|
|3:55 PM||PDT for management of nonmelanoma skin cancer in High Risk Populations / Dr. Maytin|
|4:20 PM||Prospects for PDT in inflammatory dermatoses including cystic acne / Dr. Sakamoto|
|4:45 PM||Use of 5-fluorouracil combined with PDT for field therapy of actinic keratoses / Dr. Tanghetti|
|5:10 PM||Panel Discussion: Problems and Pearls in Photodynamic Therapy / All faculty|